FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) | MicrobiomeTrials← Back to trialsNCT07111065
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-08-03Est. Completion: 2030-11-03
Enrollment target: 300 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Rheumatoid Arthritis (RA)Systemic Lupus Erthematosus (SLE)Dermatomyositis (DM)Systemic Sclerosis (SSc)
Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated activity against refractory autoimmune disease, …
Boston, United StatesEst. completion Mar 2030
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositisPolymyositisImmune-Mediated Necrotizing Myopathy
Antisynthetase Syndrome
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participant…
Phoenix, United StatesCompleted Jul 2, 2026